Background: This study aimed to describe the results of mammography done during breast cancer awareness campaigns in Lomé. Methods: This was a retrospective multicenter study which focused on the analysis of mammographic examinations, with or without breast ultrasound, carried out in three (3) clinics in Lomé over a period of five (5) years during the breast cancer awareness month (Pink October) campaigns. We included in our study women of all ages who underwent a mammography during the study period. Additional ultrasound was performed as needed in some women to better characterize a lesion. The parameters studied were socio-demographic data, and aspects of breast lesions. We classified the lesions in order of severity according to the BI-RADS classification. Results: During the study we counted one thousand and seventy-four (1074) women who underwent mammography examinations, corresponding to an average of 214.8 women per year. The median age of the women was 46 years. The most represented age group was 40 - 49, constituting 30% of cases. Mammography was performed on all women and ultrasound was performed on 51.3% of women. Lesions suspicious for malignancy (BI-RADS IV) and lesions highly suggestive of malignancy (BI-RADS V) represented 3.5% and 1.9% of cases respectively, amounting to a prevalence of 5.4%. They occurred more frequently from the age of 30 years with a statistically significant difference (p = 0.02). These lesions could be identified on mammograms as masses with irregular shapes and spiculated margins representing 16.1% and 9.7% of masses respectively. On ultrasound, these were solid masses with irregular and ill-defined borders, representing 25.2% and 5.2% of solid masses respectively. Lesions suspicious for malignancy were most often found in the UOQ (upper outer quadrant) in 70% of cases. Conclusion: Mammography screening for breast cancer remains a necessity in our community, even if the rate of cancer detected remains low. It allows for early diagnosis of cancers, promoting better management.
References
[1]
Wilson, J.M. and Jungner, G. (1970) Principes et pratiques du dépistage des maladies. Cahiers de santé publique, OMS.
[2]
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., et al. (2015) Cancer Incidence and Mortality Worldwide: Sources, Methods and Major Patterns in GLOBOCAN 2012. International Journal of Cancer, 136, 359-386.
https://doi.org/10.1002/ijc.29210
[3]
Ly, M., Antoine, M., André, F., Callard, P., Bernaudin, J.F. and Diallo, D.A. (2011) Le cancer du sein chez la femme de l’Afrique sub-saharienne: État actuel des connaissances. Bulletin du Cancer, 98, 797-806. https://doi.org/10.1684/bdc.2011.1392
[4]
Darré, T., Amégbor, K., Sonhaye, L., Kouyate, M., Aboubaraki, A., N’timom, B., Bassowa, A., Fiagnon, K., Adama, R., Klu, S. and Napo-Koura, G. (2013) Profil histo-épidémiologique des cancers du sein. A propos de 450 cas observés au CHU de Lomé. Médecine d’Afrique Noire, 60, 53-58.
[5]
Darré, T., Walla, A., Kpatcha, T.M., Aboubakari, A., Maneh, N., Koulinga, M., et al. (2016) Cancers in the Elderly Seen in Anatomical Pathology Laboratory in Lomé, Togo. Open Journal of Pathology, 6, 26-31.
https://doi.org/10.4236/ojpathology.2016.61005
[6]
Frikha, M., Yaiche, O., Elloumi, F., Mnejja, W., Slimi, L., et al. (2013) Résultats d’un essai pilote de dépistage de cancer du sein par mammographie dans la région de Sfax, Tunisie. Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 42, 252-261. https://doi.org/10.1016/j.jgyn.2013.01.007
[7]
Binder-Foucard, F., Belot, A., Delafosse, P., et al. (2013) Estimation nationale de l’incidence et de la mortalité par cancer en France entre 1980 et 2012. Étude à partir des registres des cancers du réseau Francim. INVS.
[8]
République Française, Loi n° 2004-806 du 9 août 2004 relative à la politique de santé publique, JORF du 11 août 2004.
[9]
Zaki, H.M., Garba-Bouda, O., Garba, S.M. and Nouhou, H. (2013) Profil épidémiologique et anatomopathologique du cancer du sein au Niger. Journal of African Cancer, 5, 185-191.
[10]
Ben Abdallah, M. (2010) Cancer du sein: épidémiologie, prise en charge, résultats thérapeutiques et coût. Registre de l’Institut Salah-Azaïz, Tunis, 2005.
[11]
Maalej, M., Hentati, D., Messai, T., et al. (2008) Breast Cancer in Tunisia in 2004: A Comparative Clinical and Epidemiological Study. Bulletin du Cancer, 95, 5-9.
[12]
Smith, R.A., Saslow, D., Sawyer, K.A., Burke, W., Costanza, M.E. and Evans, W.P. (2003) American Cancer Society Guidelines for Breast Cancer Screening: Update 2003. CA: A Cancer Journal for Clinicians, 53, 141-169.
https://doi.org/10.3322/canjclin.53.3.141
[13]
Seradour, B. (2004) Impact de la densité mammaire sur le dépistage. 26ème journées de la SFSPM, Nancy.
[14]
Boyd, N.F., Guo, H., Martin, L.J., et al. (2007) Mammographic Density and the Risk of Detection of Breast Cancer. The New England Journal of Medicine, 356, 227-236.
https://doi.org/10.1056/NEJMoa062790
[15]
Henrot, P., Leroux, A., Barlier, C. and Génin, P. (2013) Les microcalcifications mammaires: Quelles lésions en anatomie pathologique? Diagnostic and Interventional Imaging, 95, 145-157. https://doi.org/10.1016/j.jradio.2013.12.007
[16]
Ngou-Mve-Ngou, J.P., Mayi-Tsonga, S., Diallo Owono, F.K., Ngo’o Nze, S. and Ondo N’dong, F. (2009) Lésions infra cliniques du sein à libreville (GABON): Etude rétrospective de 174 cas. Clinics in Mother and Child Health, 6, 1003-1006.
[17]
Gest, J., et al. (1975) Cancer du sein étiologie et histoire naturelle. EMC Paris, Gynéco, 4, 865.
